Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06457230 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 24, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 1 to 2v3 Show 10 more changesShow less
    • Enrollment target: 70 to 90
    • Primary completion date: May 2026 to Jul 2026
    • Study completion date: Aug 2026 to Sep 2026
    • Interventions: Paired Associative Stimulation Targeting the Cerebellar-mPFC (Device), Sham Intervention Group (Device) to Paired Associative Stimulation Targeting the Cerebellar-mPFC (Device), Sham Intervention over cerebellum and mPFC (Device), Sham…
    • Eligibility criteria expanded, about 55 words
    • Secondary endpoints: 7 to 6
    • Study description revised
    • Collaborators: 2 to 5
    • Study arms: 2 to 3
    • Study title shortened, about 4 words
  2. Enrollment target: 40 to 70v2 Show 10 more changesShow less
    • Primary completion date: Dec 2024 to May 2026
    • Primary endpoint revised
    • Study completion date: Dec 2025 to Aug 2026
    • Start date changed from estimate of Sep 2024 to Dec 24, 2024
    • Interventions: 10Hz rTMS based on cerebellum and FPC (Device), 10Hz rTMS based on cerebellum or FPC (Device) to Paired Associative Stimulation Targeting the Cerebellar-mPFC (Device), Sham Intervention Group (Device)
    • Eligibility criteria shortened, about 67 words
    • Secondary endpoints: 5 to 7
    • Study description expanded, about 139 words
    • Collaborators expanded, about 8 words
    • Study title revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired cerebellar-medial prefrontal cortex (mPFC) pulses on methamphetamine use disorder patients and to develop a novel physiotherapeutic intervention to optimise the treatment and management.
Trial Details
NCT Number NCT06457230
Lead Sponsor Shanghai Mental Health Center
Collaborators: Chengdu Drug Rehabilitation Center, Sichuan Ziyang Compulsory Isolation Drug Rehabilitation Center, Mental Health Center, West China Hospital of Sichuan University, Chengdu, Wuhan Mental Health Center, The Ninth Clinical School, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, HanYang Comoulsory Isolation Drug Rehabilitation Center, Wuhan
Conditions
(from sponsor)		 Methamphetamine Use Disorder
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov